Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,239

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,844

Class I recallsReasonable probability of serious health consequences

24,383

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,084 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/eden-brothers-recalls-calabrese-broccoli-seeds-due-possible-salmonella-contaminationPublished October 7, 2026

Most affected stateHawaii 200 recalls mention this state

State: NJ ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 8, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,383
Class I	9,844
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,383
Class I	9,844
Class III	2,897
Not Yet Classified	2

FDA Recall TerminatedTerminated: June 5, 2018Historical recordClass I

MAXI GOLD WEIGHT LOSS PILL, bottle contains 30 CAPSULES, product is packaged in a clear plastic bottle with blue lid, gold and orange label with orange font. Distributed by: New Life nutritional, www.newlifenutritional.com under the following telephone numbers: (212) 923-6386, (212) 304-8880, (718) 329-1636 and (862) 591-2188.

by New Life Nutritional Center

Reason: Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.
Published: December 31, 2014
Distribution: Multiple states

View recall →

FDA Recall TerminatedTerminated: June 5, 2018Historical recordClass I

New Life Nutritional SUPER FAT BURNER, bottle contains 30 CAPSULES, product is packaged in a white plastic bottle with black, red and green font. Distributed by: New Life Nutritional under the following addresses: 714 West 181st Street New York, NY 10033, 153 East 188th Street Bronx, NY 10468, 316 Monroe Street Passaic, NJ 07055 and 200 Dyckman Street New York, NY 10040.

by New Life Nutritional Center

Reason: Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.
Published: December 31, 2014
Distribution: Multiple states

View recall →

FDA Recall TerminatedTerminated: January 13, 2017Historical recordClass II

MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz, UPC 6 28586 67805 7.

by Chaotic Labz

Reason: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Published: December 31, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2016Historical recordClass III

Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.

by Hospira Inc.

Reason: Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.
Published: December 31, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 6, 2015Historical recordClass I

Tropi/Cyclo/Phenyl/Tobra/Flurb (1/1/10/0.3/0.03)% Sterile Ophthalmic Solution, 1 mL Dropper in a 3 mL bottle, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.

by Pharmacy Creations

Reason: Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.
Published: December 31, 2014
Distribution: Directly to patients and physicians in F…

View recall →

FDA Recall TerminatedTerminated: July 6, 2015Historical recordClass I

Magnesium Chloride 20% (200mg/mL) Sterile Injection, 50mL Multi-Dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.

by Pharmacy Creations

Reason: Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.
Published: December 31, 2014
Distribution: Directly to patients and physicians in F…

View recall →

FDA Recall TerminatedTerminated: July 6, 2015Historical recordClass I

Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.

by Pharmacy Creations

Reason: Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.
Published: December 31, 2014
Distribution: Directly to patients and physicians in F…

View recall →

FDA Recall TerminatedTerminated: July 6, 2015Historical recordClass I

Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756.

by Pharmacy Creations

Reason: Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.
Published: December 31, 2014
Distribution: Directly to patients and physicians in F…

View recall →

FDA Recall TerminatedTerminated: August 13, 2015Historical recordClass III

Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDC 64679-735-02), b) 4000-count pack (64679-735-08), Manufactured by: Wockhardt Limited, Mumbai, India Distributed by Wockhardt USA LLC. 20 Waterview Blvd. Parsippany, NJ 07054 USA .

by Wockhardt Usa Inc.

Reason: Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.
Published: December 24, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 15, 2016Historical recordClass II

Meropenem I.V. 1 g is supplied in 30 mL injection vials, RX only. Manufactured by Hospira Healthcare India Pvt. Ltd Tamil Nadu, India for Hospira, Inc. 275 N. Field Drive, Lake Forest, IL 60045. NDC 0409-3506-01

by Hospira Inc.

Reason: Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility.
Published: December 24, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: May 21, 2015Historical recordClass III

BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.

by Eisai Inc

Reason: Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
Published: December 24, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 28, 2015Historical recordClass II

Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04

by Baxter Healthcare Corp.

Reason: Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal
Published: December 24, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 1, 2015Historical recordClass II

Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Manufactured by Prometheus Laboratories Inc. 9410 Carroll Park Drive, San Diego, CA 92121, repackaged by American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217, NDC 68084-325-21

by American Health Packaging

Reason: Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.
Published: December 24, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 25, 2017Historical recordClass II

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

by Zydus Pharmaceuticals USA Inc

Reason: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
Published: December 24, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 8, 2015Historical recordClass III

Scrub Care Chlorhexidine Gluconate Solution, 4% Surgical Hand Scrub, OTC, CareFusion, Vernon Hills, IL 60061 NDC 57613-007-25

by CareFusion 213, LLC

Reason: Does Not Meet Monograph: Chlorhexidine Gluconate Surgical Scrub Brush is being recalled due to higher concentrations of available chlorhexidine gluconate.
Published: December 17, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 12, 2014Historical recordClass II

CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Published: December 17, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 12, 2014Historical recordClass II

ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Published: December 17, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: December 12, 2014Historical recordClass II

MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials, Rx only. APP Pharmaceuticals, LLC. Schaumburg, IL 60173. NDC: 63323-412-25.

by Fresenius Kabi USA, LLC

Reason: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Published: December 17, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 2, 2015Historical recordClass II

Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II), Rx only, 25 units per box/50 units per case, Hospira Inc., Lake Forest, IL --- NDC 0409-9094-61

by Hospira Inc.

Reason: Lack of Assurance of Sterility; improperly crimped fliptop vials
Published: December 17, 2014
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 16, 2015Historical recordClass II

Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.

by Baxter Healthcare Corp.

Reason: Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.
Published: December 17, 2014
Distribution: Nationwide

View recall →

Data last updated: October 8, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.